Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · IEX Real-Time Price · USD
33.35
-1.86 (-5.28%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $2.04 billion as of April 26, 2024. Its market cap has increased by 5.76% in one year.
Market Cap
2.04B
Enterprise Value
1.74B
1-Year Change
5.76%
Ranking
Category
Stock Price
$33.35
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $2.04B, an increase of 144.23%. That is a compound annual growth rate of 27.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 2.15B | -1.40% |
Apr 23, 2024 | 2.18B | 3.96% |
Apr 22, 2024 | 2.10B | 1.12% |
Apr 19, 2024 | 2.08B | -3.27% |
Apr 18, 2024 | 2.15B | 4.03% |
Apr 17, 2024 | 2.06B | -0.50% |
Apr 16, 2024 | 2.07B | -1.34% |
Apr 15, 2024 | 2.10B | -3.35% |
Apr 12, 2024 | 2.17B | -4.38% |
Apr 11, 2024 | 2.27B | 5.32% |
Apr 10, 2024 | 2.16B | -6.06% |
Apr 9, 2024 | 2.30B | 3.41% |
Apr 8, 2024 | 2.22B | -0.09% |
Apr 5, 2024 | 2.22B | 0.44% |
Apr 4, 2024 | 2.21B | -2.40% |
Apr 3, 2024 | 2.27B | -1.35% |
Apr 2, 2024 | 2.30B | -4.52% |
Apr 1, 2024 | 2.41B | -1.94% |
Mar 28, 2024 | 2.46B | 0.07% |
Mar 27, 2024 | 2.45B | 1.72% |
Mar 26, 2024 | 2.41B | -0.02% |
Mar 25, 2024 | 2.41B | -3.00% |
Mar 22, 2024 | 2.49B | -0.24% |
Mar 21, 2024 | 2.49B | 1.22% |
Mar 20, 2024 | 2.46B | 1.92% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vericel | 2.25B |
Privia Health Group | 2.23B |
TG Therapeutics | 2.20B |
CONMED | 2.20B |
agilon health | 2.19B |
Vera Therapeutics | 2.17B |
AMN Healthcare Services | 2.17B |
Inari Medical | 2.15B |